Jaiman Manasi 4
4 · Aardvark Therapeutics, Inc. · Filed Jun 13, 2025
Insider Transaction Report
Form 4
Jaiman Manasi
Chief Medical Officer
Transactions
- Award
Stock Option (right to buy)
2025-06-11+126,999→ 126,999 totalExercise: $11.29Exp: 2035-06-11→ Common Stock (126,999 underlying)
Footnotes (1)
- [F1]1/4th of the shares subject to the option shall vest on June 11, 2026, and 1/48th of the shares subject to the option shall vest in monthly installments thereafter, subject to the Reporting Person's continuous service through each vesting date, inclusive.